Alan Walshe Thanks PPTA on Behalf of Plasma Donors And Patients Who Rely on PDMPs
Alan Walshe, Senior Vice President, Head of Global Commercial Strategy for Plasma Derived Therapies at Takeda, reposted from Anita Brikman on LinkedIn:
”This year’s Plasma Protein Forum, taking place in Washington DC, is tackling the most urgent issues facing Plasma-Derived Medicinal Products (PDMPs) including growing patient need, plasma donor health and the vital importance of partnering with regulators and other stakeholders.
Thank you Plasma Protein Therapeutics Association (PPTA) for your important work on behalf of plasma donors and patients who rely on PDMPs.”
Quoting Anita Brikman‘s post:
”Day one of the Plasma Protein Forum set a powerful tone for collaboration, innovation, and impact across the plasma community.
Plasma Protein Therapeutics Association (PPTA) Global Executive Board Chair Giles Platford began the day by reminding attendees of the importance of science-driven progress and global partnership.
Dr. Namandje Bumpus continued that discussion by delivering a collaborative keynote on regulatory excellence.
Sessions then moved to thought-provoking examinations on trade, donor health, state policy, and innovation.
Each session underscored the industry’s shared commitment to donors and patients.
A special thank you to all speakers, moderators, and sponsors who made today’s sessions and networking moments so engaging.
I am excited to see what tomorrow will bring at PPF2025.”
More from PPF2025 featured in Hemostasis Today.
-
Jun 10, 2026, 04:15Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
-
Jun 10, 2026, 04:02Heghine Khachatryan: What Should We Test From a Hematologic Perspective in Young Cryptogenic Stroke?
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients